Effects of manidipine and nifedipine on blood pressure and renal function in patients with chronic renal failure: A multicenter randomized controlled trial

Renal Failure

Volumn 25, Issue 5, 2003, Pages 681-689

  Bellinghieri, Guido ^a   Mazzaglia, Giampiero ^b   Savica, Vincenzo ^a   Santoro, Domenico ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b Health Search Database   (Italy)

Author keywords

Hypertension; Kidney failure; Manidipine; Nifedipine; Randomized controlled trial; Side effects

Indexed keywords

CREATININE; MANIDIPINE; NIFEDIPINE; POTASSIUM ION; SODIUM ION;

ADULT; AGED; ANKLE EDEMA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA;

ADULT; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; DIHYDROPYRIDINES; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NIFEDIPINE; TREATMENT OUTCOME; URINARY TRACT PHYSIOLOGY;

EID: 0141841760     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-120024284     Document Type: Article

References (17)

1. Whelton, P.K. Epidemiology of hypertension. Lancet 1994, 344, 101-106.
2. Working Group on Primary Prevention of Hypertension. Report of the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension. Archives of Internal Medicine 1993, 151, 186-208.
3. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Archives of Internal Medicine 1993, 153, 154-183.
4. Danielson, H.; Kornerup, H.; Olsen, S.; Posberg, V. Arterial hypertension in chronic glomerulonephritis. An analysis of 310 cases. Clinical Nephrology 1983, 19, 3353-3358.
5. Brazy, P.C.; Fitzwilliam, J.F. Progressive renal disease: role of race and antihypertensive medications. Kidney International 1990, 37, 1113-1119.
6. The National High Blood Pressure Education Program Working Group: National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes. Hypertension 1994, 8, 2-6.
7. Epstein, M. Calcium antagonists and renal protection: current status and future perspectives. Archives of Internal Medicine 1992, 152, 1573-1584.
8. Bretzel, R.G. Protecting the residual renal function: which drugs of choice? American Journal of Hypertension 1997, 10, 159s-166s.
9. Takabatake, T.; Ohta, H.; Sasaki, T.; Satoh, S.; Ohta, K.; Ise, T.; Kobayashi, K. Renal effects of manidipine hydrochloride. European Journal of Clinical Pharmacology 1993, 45, 321-325.
10. Gault, M.H.; Longerich, L.L.; Harnett, J.D.; Wesolowsky, C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992, 62, 249-256.
11. Neaton, J.D.; Grimm, R.H., Jr.; Prineas, R.J. Treatment of mild hypertension study. JAMA 1993, 270, 713-724.
12. Elliot, W.J. Drug therapy and drops out in a tertiary hypertension clinic. American Journal of Hypertension 1994, 25, 1356.
13. Fogari, R.; Zoppi, A.; Corradi, L.; Preti, P.; Malalamani, G.D.; Mugellini, A. Effect of different dyhydropyridine calcium antagonist on plasma norepinephrine in essential hypertension. J. Hypertens. 2000, 18, 1871-1875.
14. Van Zwieten, P.A.; Pfaffendorf, M.; Mancia, G. Attempts to improve the selectivity of calcium antagonistic drugs. Blood Pressure 1996, 5 (suppl 5), 7-9.
15. Epstain, M. Calcium antagonist and the kidney. American Journal of Hypertension 1993, 6, 251s-259s.
16. Sabbatini, M.; Leonardi, A.; Testa, R.; Vitaioli, L.; Amenta, F. Effects of calcium antagonists on glomerular arterioles in spontaneously hypertensive rats. Hypertension 2000, 35, 775-779.
17. Keane, W.J.; Raij, L. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. Laboratory Investigation 1985, 52, 599-604.